Merrill Lynch UK Inv Tst PLC
16 July 2002
MONTHLY PERFORMANCE
MERRILL LYNCH UK INVESTMENT TRUST plc
All information is at 28 June 2002 and unaudited.
Performance at month end with net income reinvested
One Three One Three Five
month months year years years
Net asset value -9.2% -14.7% -24.8% -35.2% -6.8%
Share price -7.5% -14.4% -30.6% -41.5% -17.5%
FTSE All-Share Index -8.4% -10.9% -14.8% -17.4% 17.6%
Sources: Merrill Lynch Investment Managers, Standard & Poor's Micropal
At month end
Net asset value* 770.83p
Share price: 655.00p
Discount: 15.0%
Total assets: £142.3m
Net Yield: 4.4%
Gearing: 38.5%
Effective gearing: 14.8%
Value of debt: £39.5m
Ordinary shares in issue: 13,393,799
*Includes current year net revenue of 3.86p.
UK Sectors % Total Assets
Financials 25.5
Non-Cyclical Consumer Goods 16.0
Cyclical Services 13.5
Resources 12.8
Non-Cyclical Services 7.8
General Industrials 2.4
Basic Industries 1.9
Information Technology 1.7
Utilities 1.3
Cash 17.9
Net current liabilities (0.8)
Total 100.0
Ten Largest Equity Investments
Company
% Investments
BP Amoco 9.6
Barclays 5.9
HSBC 5.7
HBOS 5.3
Royal Bank of Scotland 5.2
GlaxoSmithKline 5.2
AstraZeneca 5.1
Vodafone 3.9
Diageo 3.4
Amersham 3.3
Total 52.6
Market commentary
UK Stockmarket Review
UK equities fell sharply over the month, with the FTSE All-Share falling 8.4%
and the FTSE 100 8.3% in sterling terms. The UK stockmarkets suffered along with
shares globally as investors' confidence in corporate accounting practices
weakened after WorldCom announced irregularities in its accounts.
Performance Review
The Company's Net Asset Value (NAV) fell 9.2% during May, underperforming the
FTSE All-Share Index.
Banking shares, which had performed well for much of the second quarter, fell
back during June after a profit warning from Abbey National. The Company
benefited from our choice of shares in this sector, largely through not holding
Abbey National and Lloyds TSB, although this was slightly offset by our
overweight position in HBOS. Also within the financials sector, our underweight
position in life assurance, particularly our avoidance of Aviva (formerly CGNU)
was beneficial).
The Company continued to benefit from holdings in defensive areas, including
beverages company Diageo. Conversely, performance was adversely affected by
several of our media holdings as this sector performed poorly over the month.
Holdings including Chrysalis, BSkyB and Reuters were negative contributors.
Outlook
Despite the economy's low nominal growth environment, there are a number of
trends within the UK that we expect to enhance earnings growth for a number of
companies held in the Company. These include outsourcing, pricing power, volume
growth and corporate restructuring. Our focus on stock selection based on
fundamental research should enable us to access these themes.
Latest information is available by typing www.mlim.co.uk/its on the internet,
'MLIMINDEX' on Reuters, 'MLIM' on Bloomberg or '8800' on Topic 3 (ICV terminal).
16 July 2002
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.